Brief: Humacyte, Inc. Announces Pricing Of $40.2 Million Public Offering Of Common Stock
Feb 29 (Reuters) - Humacyte Inc HUMA.O :
* HUMACYTE, INC. ANNOUNCES PRICING OF $40.2 MILLION PUBLIC
OFFERING OF COMMON STOCK
* HUMACYTE INC - UNDERWRITTEN PUBLIC OFFERING OF 13.4
MILLION
SHARES AT $3 PER SHARE
Source text for Eikon: ID:nGNX8k3clm
Further company coverage: HUMA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Humacyte
See all newsBrief: Humacyte Announces Lancet Digital Health Publication Of V007 Phase 3 Hemodialysis Access Trial Results
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte, CoreWeave
U.S. STOCKS ON THE MOVE-Sutro Biopharma, Humacyte
Humacyte falls after wider-than-expected quarterly loss
Humacyte Inc reports results for the quarter ended June 30 - Earnings Summary